{"id":"doi:10.1056/nejmoa2502082","kind":"article","title":"Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes","authors":["Melanie Jane Davies","HARPREET SINGH BAJAJ","Christa Broholm","Astrid Eliasen","William Timothy Garvey","Carel Wynand le Roux","Ildiko Lingvay","Christian Bøge Lyndgaard","Julio Rosenstock","Sue D. Pedersen"],"author_count":10,"year":2025,"published":"2025-06-22","venue":"New England Journal of Medicine","cited_by":143,"doi":"10.1056/nejmoa2502082","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2502082","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2502082","updated":null,"pmid":"40544432","pmcid":null,"openalex_id":"W4411522182","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}